U.S. Capital Wealth Advisors, LLC Amicus Therapeutics, Inc. Transaction History
U.S. Capital Wealth Advisors, LLC
- $3.48 Billion
- Q4 2025
A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 10,062 shares of FOLD stock, worth $95,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,062Holding current value
$95,387% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
325Shares Held
319MCall Options Held
1.09MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA29.7MShares$282 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.6MShares$271 Million0.04% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$231 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL15.7MShares$149 Million0.35% of portfolio
-
Avoro Capital Advisors LLC New York, NY15MShares$142 Million1.62% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.66B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...